Abstract
A mathematical model for two strains of Malaria and Cholera with optimal control is studied and analyzed to assess the impact of treatment controls in reducing the burden of the diseases in a population, in the presence of malaria drug resistance. The model is shown to exhibit the dynamical property of backward bifurcation when the associated reproduction number is less than unity. The global asymptotic stability of the disease-free equilibrium of the model is proven not to exist. The necessary conditions for the existence of optimal control and the optimality system for the model is established using the Pontryagin’s Maximum Principle. Numerical simulations of the optimal control model reveal that malaria drug resistance can greatly influence the co-infection cases averted, even in the presence of treatment controls for co-infected individuals.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.who.int/malaria/publications/
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Federal University of Technology Owerri, Nigeria
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors names rearranged properly in Medrxiv
